Literature DB >> 19049592

Genetic influences on ketogenic diet efficacy.

Stacey B B Dutton1, Andrew Escayg.   

Abstract

An average of 15-20% of patients on the ketogenic diet (KD) experience a >50% reduction in seizure frequency; however, 10-40% discontinue the diet due to either a lack of response or adverse side effects. This variability in patient response raises the possibility that genetic factors may influence the efficacy of the KD. As a first step towards identifying these factors, we evaluated the ability of the KD to alter seizure thresholds in four commonly used inbred mouse strains: C57BL/6J, FVB/NJ, A/J, and DBA/2J. We observed strain-specific differences, indicating that genetic factors are likely to influence efficacy.

Entities:  

Mesh:

Year:  2008        PMID: 19049592      PMCID: PMC2653419          DOI: 10.1111/j.1528-1167.2008.01839.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  18 in total

1.  De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.

Authors:  L Claes; J Del-Favero; B Ceulemans; L Lagae; C Van Broeckhoven; P De Jonghe
Journal:  Am J Hum Genet       Date:  2001-05-15       Impact factor: 11.025

2.  Genetic correlations among inbred strain sensitivities to convulsions induced by 9 convulsant drugs.

Authors:  A E Kosobud; J C Crabbe
Journal:  Brain Res       Date:  1990-08-27       Impact factor: 3.252

3.  The ketogenic diet in refractory childhood epilepsy.

Authors:  Mark T Mackay; Jillian Bicknell-Royle; Judy Nation; Maureen Humphrey; A Simon Harvey
Journal:  J Paediatr Child Health       Date:  2005-07       Impact factor: 1.954

4.  Ketogenic diet in patients with Dravet syndrome and myoclonic epilepsies in infancy and early childhood.

Authors:  Natalio Fejerman; Roberto Caraballo; Ricardo Cersosimo
Journal:  Adv Neurol       Date:  2005

5.  Neuropathologic findings associated with seizures in FVB mice.

Authors:  M F Goelz; J Mahler; J Harry; P Myers; J Clark; J E Thigpen; D B Forsythe
Journal:  Lab Anim Sci       Date:  1998-02

6.  Efficacy of the ketogenic diet in focal versus generalized seizures.

Authors:  B V Maydell; E Wyllie; N Akhtar; P Kotagal; K Powaski; K Cook; A Weinstock; A D Rothner
Journal:  Pediatr Neurol       Date:  2001-09       Impact factor: 3.372

Review 7.  How do mutant Nav1.1 sodium channels cause epilepsy?

Authors:  David S Ragsdale
Journal:  Brain Res Rev       Date:  2008-02-07

8.  The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children.

Authors:  J M Freeman; E P Vining; D J Pillas; P L Pyzik; J C Casey; L M Kelly
Journal:  Pediatrics       Date:  1998-12       Impact factor: 7.124

9.  Seizure susceptibility in DBA and C57 mice: the effects of various convulsants.

Authors:  F L Engstrom; D M Woodbury
Journal:  Epilepsia       Date:  1988 Jul-Aug       Impact factor: 5.864

10.  Differential sensitivity to bicuculline in three inbred mouse strains.

Authors:  R K Freund; R J Marley; J M Wehner
Journal:  Brain Res Bull       Date:  1987-05       Impact factor: 4.077

View more
  5 in total

1.  Protective effect of the ketogenic diet in Scn1a mutant mice.

Authors:  Stacey B B Dutton; Nikki T Sawyer; Franck Kalume; Patricia Jumbo-Lucioni; Karin Borges; William A Catterall; Andrew Escayg
Journal:  Epilepsia       Date:  2011-07-29       Impact factor: 5.864

2.  A novel variant in the 3' UTR of human SCN1A gene from a patient with Dravet syndrome decreases mRNA stability mediated by GAPDH's binding.

Authors:  Tao Zeng; Zhao-Fei Dong; Shu-Jing Liu; Rui-Ping Wan; Ling-Jia Tang; Ting Liu; Qi-Hua Zhao; Yi-Wu Shi; Yong-Hong Yi; Wei-Ping Liao; Yue-Sheng Long
Journal:  Hum Genet       Date:  2014-01-25       Impact factor: 4.132

3.  Anticonvulsant Effects of β-Hydroxybutyrate in Mice.

Authors:  Mi-Sun Yum; Tae-Sung Ko; Dong Wook Kim
Journal:  J Epilepsy Res       Date:  2012-12-30

4.  Variants in KCNJ11 and BAD do not predict response to ketogenic dietary therapies for epilepsy.

Authors:  Natasha E Schoeler; Costin Leu; Jon White; Vincent Plagnol; Sian Ellard; Mar Matarin; Gary Yellen; Elizabeth A Thiele; Mark Mackay; Jacinta M McMahon; Ingrid E Scheffer; Josemir W Sander; J Helen Cross; Sanjay M Sisodiya
Journal:  Epilepsy Res       Date:  2015-10-24       Impact factor: 3.045

5.  Genome-wide association study: Exploring the genetic basis for responsiveness to ketogenic dietary therapies for drug-resistant epilepsy.

Authors:  Natasha E Schoeler; Costin Leu; Simona Balestrini; Jonathan M Mudge; Charles A Steward; Adam Frankish; Mary-Anne Leung; Mark Mackay; Ingrid Scheffer; Ruth Williams; Josemir W Sander; J Helen Cross; Sanjay M Sisodiya
Journal:  Epilepsia       Date:  2018-07-16       Impact factor: 5.864

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.